Kestra Medical (KMTS) CCO Alfred Ford Receives 58,832-Share Award

What Happened
Alfred J. Ford Jr., Chief Commercial Officer of Kestra Medical Technologies, received 58,832 common shares on July 15, 2026 pursuant to performance-based restricted stock units (PSUs). The shares are reported as acquired at $0.00 (award/vesting); the PSUs were granted July 17, 2025 and 100% vested on July 15, 2026 per the filing. The Form 4 was filed on July 17, 2026 (timely).

Key Details

• Transaction date: July 15, 2026 — Transaction code: A (award/grant).
• Shares acquired: 58,832 common shares at $0.00 per share (award vesting).
• Footnote: PSUs granted July 17, 2025 vested in full based on achievement of specified performance goals (F1).
• Filing date: July 17, 2026 (appears timely under Form 4 rules).
• Shares owned after transaction: not disclosed in the provided filing.

Context
PSUs are performance-based equity awards that convert to shares only if performance targets are met; this filing reflects compensation vesting rather than an open-market buy or sale. Such awards represent executive compensation and do not necessarily signal a trading decision; they may be subject to tax withholding or company holding rules (not detailed in this filing).